Weave Communications, Inc. (WEAV)
NYSEHealth CareSoftware - ApplicationSnapshot 2026-11-04
$7.40+0.14%
Close 2026-10-23 · 1-day change
NYSEHealth CareSoftware - ApplicationSnapshot 2026-11-04
Research Workspace
Put WEAV beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar under pressure — Non-GAAP operating income $10.5M-$13.5M for FY26: Direct metric needs a verified mapping.
View ThesisRevenue is growing steadily — about 17% over the past year.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 58% growth a year, above the roughly 17% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 0% on a typical day and fell roughly 42% in its worst 12-month stretch.
View RiskWeave's AI patient engagement platform has to keep compounding to justify the price. Revenue grew 15.5% year over year in the latest quarter. The company beat its earnings estimate by 157.1%. It trades at 2.3 times sales versus a 1.8 times peer median. The market is pricing in more growth than we forecast. The primary pillar is under pressure on operating income. The thesis comparison is not yet verified. Peer multiples imply a price about 1.2% above where it trades. Our read is provisional. The thesis is on watch.
Trailing returns as of 2026-10-23. WEAV is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 4 analysts currently covering WEAV (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for WEAV in the last 4 months.
Continue this research
Compare WEAV with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| WEAV Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Health Care Technology — fair value, gap to price, and forward P/E.
Compare the value case
Put WEAV next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand AI-powered patient engagement platform capabilities
Integration enhances AI-powered patient engagement platform capabilities.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-23. EPS is implied from price ÷ P/E. Not investment advice.
Current $7.40
The last 12 months of price, then the range of analyst 12-month targets from today’s $7.40.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Stock rating cut raises concerns about future performance.
Buyout deal enhances growth potential and market position.
Acquisition deal concerns may affect growth outlook.
Advances: Increase customer location additions and market penetration
Shift to consumption pricing supports market penetration.
